Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Vasculitis
•
General Rheumatology
•
Polymyalgia rheumatica
What would be the preferred treatment option for PMR if patient develops gastric perforation soon after initiation of steroids?
Related Questions
Is polymyalgia rheumatica associated with increased toxicity for lung SBRT?
How will you approach drug sequencing in patients with PMR given the SAPHYR data?
How would you approach management of incidentally identified unilateral retinal vasculitis with subsequent labs revealing +P-ANCA?
At what point do you consider a patient to have relapsing PMR?
What else do you consider in the differential diagnosis for pulmonary-renal syndromes if there is low clinical and serologic evidence of AAV, Goodpasture's or other rheumatologic disease (SLE, RA, APS, Scleroderma)?
How would you approach evaluation of a patient with multiple vertebral artery pseudoaneurysms and history of dissection, but without other areas of pseudoaneurysms?
What baseline and ongoing testing do you recommend for patients with PMR who are going to be on a prolonged steroid taper?
How do you manage a patient with cervical cancer who has FDG uptake in bilateral ischial tuberosities with lytic areas on CT correlate, and also has a history suspicious for untreated polymyalgia rheumatica with chronic symptoms in the same anatomic locations?
How will you adjust your approach to steroid taper in patients with PMR also on sarilumab?
How do you approach the work up of pulmonary artery aneurysm in the absence of other clinical features of Behcet’s?
